<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">porozendo</journal-id><journal-title-group><journal-title xml:lang="ru">Остеопороз и остеопатии</journal-title><trans-title-group xml:lang="en"><trans-title>Osteoporosis and Bone Diseases</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-2680</issn><issn pub-type="epub">2311-0716</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/osteo13136</article-id><article-id custom-type="elpub" pub-id-type="custom">porozendo-13136</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ СЛУЧАИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CASE REPORTS</subject></subj-group></article-categories><title-group><article-title>Особенности течения пахидермопериостоза с верифицированной мутацией в гене европейского типа</article-title><trans-title-group xml:lang="en"><trans-title>Features of the clinical course of pachydermoperiostosis with a verified mutation in the European type gene</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8590-1224</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фролова</surname><given-names>Т. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Frolova</surname><given-names>T. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фролова Татьяна Михайловна - клинический ординатор.</p><p>117036, Москва, ул. Дм. Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Tatyana M. Frolova - MD, resident.</p><p>11 Dm. Ulyanova street, 117036 Moscow</p></bio><email xlink:type="simple">frolova.tatiana@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2320-1051</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Голоунина</surname><given-names>О. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Golounina</surname><given-names>O. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Голоунина Ольга Олеговна - студент.</p><p>Москва</p></bio><bio xml:lang="en"><p>Olga O. Golounina - Student, Medical faculty.</p><p>Moscow</p></bio><email xlink:type="simple">olga.golounina@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9783-3599</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мамедова</surname><given-names>Е. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Mamedova</surname><given-names>E. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мамедова Елизавета Октаевна – старший научный сотрудник отделения остеопороза и остеопатий, кандидат медицинских наук.</p><p>117036, Москва, ул. Дм. Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Elizaveta O. Mamedova - MD, PhD.</p><p>11 Dm. Ulyanova street, 117036 Moscow</p></bio><email xlink:type="simple">lilybet@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4830-0152</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Литвинова</surname><given-names>Е. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Litvinova</surname><given-names>E. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Литвинова Елена Евгеньевна - врач-рентгенолог.</p><p>117036, Москва, ул. Дм. Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Elena E. Litvinova – MD.</p><p>11 Dm. Ulyanova street, 117036 Moscow</p></bio><email xlink:type="simple">litvinova.elena@endocrincentr.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6674-6441</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белая</surname><given-names>Ж. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Belaya</surname><given-names>Zh. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Белая Жанна Евгеньевна – заведующая отделением остеопороза и остеопатий, доктор медицинских наук, профессор.</p><p>117036, Москва, ул. Дм. Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Zhanna E. Belaya - MD, PhD, Professor.</p><p>11 Dm. Ulyanova street, 117036 Moscow</p></bio><email xlink:type="simple">jannabelaya@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБУ «НМИЦ эндокринологии» Минздрава России<country>Россия</country></aff><aff xml:lang="en">Endocrinology Research Center<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России (Сеченовский Университет)<country>Россия</country></aff><aff xml:lang="en">I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>15</day><month>11</month><year>2023</year></pub-date><volume>26</volume><issue>2</issue><fpage>21</fpage><lpage>27</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Фролова Т.М., Голоунина О.О., Мамедова Е.О., Литвинова Е.Е., Белая Ж.Е., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Фролова Т.М., Голоунина О.О., Мамедова Е.О., Литвинова Е.Е., Белая Ж.Е.</copyright-holder><copyright-holder xml:lang="en">Frolova T.M., Golounina O.O., Mamedova E.O., Litvinova E.E., Belaya Z.E.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.osteo-endojournals.ru/jour/article/view/13136">https://www.osteo-endojournals.ru/jour/article/view/13136</self-uri><abstract><p>Пахидермопериостоз (первичная гипертрофическая остеоартропатия) — орфанное заболевание, к основным клиническим проявлениям которого относятся булавовидная деформация пальцев по типу «барабанных палочек», периостоз (невоспалительные изменения надкостницы) трубчатых костей, пахидермия лица (гипертрофия и гиперплазия всех слоев кожи). К настоящему времени известны два гена, ассоциированных с развитием пахидермопериостоза, — HPGD и SLCO2A1. Мутации в данных генах приводят к нарушению метаболизма простагландина E2. В статье приводится описание клинического случая пациентки с пахидермопериостозом, у которой при проведении молекулярно-генетического исследования выявлены две мутации в гене HPGD: в 1 (chr4-174522451-T-A, NM_000860.6:c.1A&gt;T) и во 2 (chr4-174521985-AG-, NM_000860.6:c.175_176del) экзонах в компаунд-гетерозиготном состоянии, при этом мутация c.1A&gt;T ранее была однократно описана, а выявленное биаллельное сочетание мутаций в гене HPGD ранее в литературе не встречалось. Представленный клинический случай пахидермопериостоза — второй из описываемых в российской популяции и первый с подтвержденными мутациями в гене HPGD. Статья расширяет знания об ассоциации между генотипом и фенотипом при пахидермопериостозе, что способствует более быстрой и правильной интерпретации генетической информации при проведении генетического консультирования.</p></abstract><trans-abstract xml:lang="en"><p>Pachydermoperiostosis (primary hypertrophic osteoarthropathy) is an orphan disease, the main clinical manifestations of which include pin-shaped deformity of the fingers according to the type of «drumsticks», periostosis (non-inflammatory changes of the periosteum) of tubular bones, pachydermia of the face (hypertrophy and hyperplasia of all skin layers). Two genes associated with the development of pachydermoperiostosis are known — HPGD and SLCO2A1. Mutations in these genes lead to impaired prostaglandin E2 metabolism. This article describes a clinical case of a patient with pachydermoperiostosis, in which two mutations in the HPGD gene were detected during a molecular genetic study: in 1 exon (chr4-174522451-T-A, NM_000860.6:c.1A&gt;T) and in 2 exon (chr4-174521985-AG-, NM_000860.6:c.175_176del) in compound-heterozygous state, while the c.1A&gt;T mutation was previously described once, and the revealed biallelic combination of mutations in the HPGD gene was not previously found in the literature. This clinical case of pachydermoperiostosis is the second described in the Russian population, and the first with confirmed mutations in the HPGD gene. The article expands the knowledge about the correlation of genotype and phenotype in pachydermoperiostosis, which contributes to a faster and more correct interpretation of genetic information during genetic counseling.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>пахидермопериостоз</kwd><kwd>первичная гипертрофическая остеоартропатия</kwd><kwd>простагландин E2</kwd><kwd>SLCO2A1</kwd><kwd>HPGD</kwd><kwd>клинический случай</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pachydermoperiostosis</kwd><kwd>primary hypertrophic osteoarthropathy</kwd><kwd>prostaglandin E2</kwd><kwd>SLCO2A1</kwd><kwd>HPGD</kwd><kwd>case report</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Castori M, Sinibaldi L, Mingarelli R, et al. Pachydermoperiostosis: an update. Clin Genet. 2005;68(6):477-486. doi: https://doi.org/10.1111/j.1399-0004.2005.00533.x</mixed-citation><mixed-citation xml:lang="en">Castori M, Sinibaldi L, Mingarelli R, et al. Pachydermoperiostosis: an update. Clin Genet. 2005;68(6):477-486. doi: https://doi.org/10.1111/j.1399-0004.2005.00533.x</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Jajic I, Jajic Z. Prevalence of primary hypertrophic osteoarthropathy in selected population. Clin Ex Rheum. 1992;(10):73</mixed-citation><mixed-citation xml:lang="en">Jajic I, Jajic Z. Prevalence of primary hypertrophic osteoarthropathy in selected population. Clin Ex Rheum. 1992;(10):73</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lee S, Park SY, Kwon HJ, et al. Identification of the mutations in the prostaglandin transporter gene, SLCO2A1 and clinical characterization in Korean patients with pachydermoperiostosis. J Korean Med Sci. 2016;31(5):735-742. doi: https://doi.org/10.3346/jkms.2016.31.5.735</mixed-citation><mixed-citation xml:lang="en">Lee S, Park SY, Kwon HJ, et al. Identification of the mutations in the prostaglandin transporter gene, SLCO2A1 and clinical characterization in Korean patients with pachydermoperiostosis. J Korean Med Sci. 2016;31(5):735-742. doi: https://doi.org/10.3346/jkms.2016.31.5.735</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Uppal S, Diggle CP, Carr IM, et al. Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet. 2008;40(6):789-793. doi: https://doi.org/10.1038/ng.153</mixed-citation><mixed-citation xml:lang="en">Uppal S, Diggle CP, Carr IM, et al. Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet. 2008;40(6):789-793. doi: https://doi.org/10.1038/ng.153</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Abdullah NRA, Jason WLC, Nasruddin AB. Pachydermoperiostosis: a rare mimicker of acromegaly. Endocrinol Diabetes Metab Case Reports. 2017;2017. doi: https://doi.org/10.1530/EDM-17-0029</mixed-citation><mixed-citation xml:lang="en">Abdullah NRA, Jason WLC, Nasruddin AB. Pachydermoperiostosis: a rare mimicker of acromegaly. Endocrinol Diabetes Metab Case Reports. 2017;2017. doi: https://doi.org/10.1530/EDM-17-0029</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Z, Xia W, He J, et al. Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy. Am J Hum Genet. 2012;90(1):125-132. doi: https://doi.org/10.1016/j.ajhg.2011.11.019</mixed-citation><mixed-citation xml:lang="en">Zhang Z, Xia W, He J, et al. Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy. Am J Hum Genet. 2012;90(1):125-132. doi: https://doi.org/10.1016/j.ajhg.2011.11.019</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Z, He JW, Fu WZ, et al. Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization. J Clin Endocrinol Metab. 2013;98(5):923-933. doi: https://doi.org/10.1210/jc.2012-3568.</mixed-citation><mixed-citation xml:lang="en">Zhang Z, He JW, Fu WZ, et al. Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization. J Clin Endocrinol Metab. 2013;98(5):923-933. doi: https://doi.org/10.1210/jc.2012-3568.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Xu Y, Zhang Z, Yue H, et al. Monoallelic mutations in SLCO2A1 cause autosomal dominant primary hypertrophic osteoarthropathy. J Bone Miner Res. 2021;36(8):1459-1468. doi: https://doi.org/10.1002/jbmr.4310</mixed-citation><mixed-citation xml:lang="en">Xu Y, Zhang Z, Yue H, et al. Monoallelic mutations in SLCO2A1 cause autosomal dominant primary hypertrophic osteoarthropathy. J Bone Miner Res. 2021;36(8):1459-1468. doi: https://doi.org/10.1002/jbmr.4310</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Sinha GP, Curtis P, Haigh D, et al. Pachydermoperiostosis in childhood. Br J Rheumatol. 1997;36(11):1224-1227. doi: https://doi.org/10.1093/rheumatology/36.11.1224</mixed-citation><mixed-citation xml:lang="en">Sinha GP, Curtis P, Haigh D, et al. Pachydermoperiostosis in childhood. Br J Rheumatol. 1997;36(11):1224-1227. doi: https://doi.org/10.1093/rheumatology/36.11.1224</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tariq M, Azeem Z, Ali G, et al. Mutation in the HPGD gene encoding NAD+ dependent 15-hydroxyprostaglandin dehydrogenase underlies isolated congenital nail clubbing (ICNC). J Med Genet. 2009;46(1):14-20. doi: https://doi.org/10.1136/jmg.2008.061234</mixed-citation><mixed-citation xml:lang="en">Tariq M, Azeem Z, Ali G, et al. Mutation in the HPGD gene encoding NAD+ dependent 15-hydroxyprostaglandin dehydrogenase underlies isolated congenital nail clubbing (ICNC). J Med Genet. 2009;46(1):14-20. doi: https://doi.org/10.1136/jmg.2008.061234</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Umair M, Bilal M, Shah K, et al. Homozygous missense variant in the Solute Carrier Organic Anion Transporter 2A1 (SLCO2A1) gene underlies isolated nail clubbing. Genes (Basel). 2023;14(2):430. doi: https://doi.org/10.3390/genes14020430</mixed-citation><mixed-citation xml:lang="en">Umair M, Bilal M, Shah K, et al. Homozygous missense variant in the Solute Carrier Organic Anion Transporter 2A1 (SLCO2A1) gene underlies isolated nail clubbing. Genes (Basel). 2023;14(2):430. doi: https://doi.org/10.3390/genes14020430</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">González LA, Quintero-González DC, Vanegas-García AL. Digital clubbing, joint pain, and skin changes in a young man: primary hypertrophic osteoarthropathy. Clin Rheumatol. 2022;41(10):3253-3255. doi: https://doi.org/10.1007/s10067-022-06244-6</mixed-citation><mixed-citation xml:lang="en">González LA, Quintero-González DC, Vanegas-García AL. Digital clubbing, joint pain, and skin changes in a young man: primary hypertrophic osteoarthropathy. Clin Rheumatol. 2022;41(10):3253-3255. doi: https://doi.org/10.1007/s10067-022-06244-6</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Latos-Bielenska A, Marik I, Kuklik M, et al. Pachydermoperiostosis–critical analysis with report of five unusual cases. Eur J Pediatr. 2007;166(12):1237-1243. doi: https://doi.org/10.1007/s00431-006-0407-6</mixed-citation><mixed-citation xml:lang="en">Latos-Bielenska A, Marik I, Kuklik M, et al. Pachydermoperiostosis–critical analysis with report of five unusual cases. Eur J Pediatr. 2007;166(12):1237-1243. doi: https://doi.org/10.1007/s00431-006-0407-6</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Фурсенко В.А., Гребенникова Т.А., Никитин А.Г., Белая Ж.Е. Пахидермопериостоз: особенности диагностики на примере клинического случая // Остеопороз и остеопатии. — 2017. — Т. 20. — №2. — С. 52-57. doi: https://doi.org/10.14341/osteo9354</mixed-citation><mixed-citation xml:lang="en">Fursenko VA, Grebennikova TA, Nikitin AG, Belaya ZE. Pachydermoperiostosis: a case report. Osteoporosis and Bone Diseases. 2017;20(2):52-57. (In Russ). doi: https://doi.org/10.14341/osteo9354</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wójtowicz J, Kołodziejczyk B, Gazda A, Gietka P. Primary hypertrophic osteoarthropathy - a rare cause of pain and arthritis in children. Description of 5 cases. Cent Eur J Immunol. 2022;47(3):280-287. doi: https://doi.org/10.5114/ceji.2022.120171</mixed-citation><mixed-citation xml:lang="en">Wójtowicz J, Kołodziejczyk B, Gazda A, Gietka P. Primary hypertrophic osteoarthropathy - a rare cause of pain and arthritis in children. Description of 5 cases. Cent Eur J Immunol. 2022;47(3):280-287. doi: https://doi.org/10.5114/ceji.2022.120171</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Cooper RG, Freemont AJ, Riley M, et al. Bone abnormalities and severe arthritis in pachydermoperiostosis. Ann Rheum Dis. 1992;51(3):416-419. doi: https://doi.org/10.1136/ard.51.3.416.</mixed-citation><mixed-citation xml:lang="en">Cooper RG, Freemont AJ, Riley M, et al. Bone abnormalities and severe arthritis in pachydermoperiostosis. Ann Rheum Dis. 1992;51(3):416-419. doi: https://doi.org/10.1136/ard.51.3.416.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ibba S, Piga M, Congia M, et al. Pachidermoperiostosis as a cause of massive joint effusion with polyarticular involvement mimicking juvenile idiopathic arthritis: A case report. Joint Bone Spine. 2016;83(1):113-114. doi: https://doi.org/10.1016/j.jbspin.2015.03.001</mixed-citation><mixed-citation xml:lang="en">Ibba S, Piga M, Congia M, et al. Pachidermoperiostosis as a cause of massive joint effusion with polyarticular involvement mimicking juvenile idiopathic arthritis: A case report. Joint Bone Spine. 2016;83(1):113-114. doi: https://doi.org/10.1016/j.jbspin.2015.03.001</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Yuan L, Liao R, Lin Y, et al. Safety and efficacy of cyclooxygenase-2 inhibition for treatment of primary hypertrophic osteoarthropathy: A single-arm intervention trial. J Orthop Transl. 2019;(18):109-118. doi: https://doi.org/10.1016/j.jot.2018.10.001</mixed-citation><mixed-citation xml:lang="en">Yuan L, Liao R, Lin Y, et al. Safety and efficacy of cyclooxygenase-2 inhibition for treatment of primary hypertrophic osteoarthropathy: A single-arm intervention trial. J Orthop Transl. 2019;(18):109-118. doi: https://doi.org/10.1016/j.jot.2018.10.001</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Tsuzuki Y, Aoyagi R, Miyaguchi K, et al. Chronic Enteropathy Associated with SLCO2A1 with Pachydermoperiostosis. Intern Med. 2020;59(24):3147-3154. doi: https://doi.org/10.2169/internalmedicine.4756-20</mixed-citation><mixed-citation xml:lang="en">Tsuzuki Y, Aoyagi R, Miyaguchi K, et al. Chronic Enteropathy Associated with SLCO2A1 with Pachydermoperiostosis. Intern Med. 2020;59(24):3147-3154. doi: https://doi.org/10.2169/internalmedicine.4756-20</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Q, Li YH, Lin GL, et al. Primary hypertrophic osteoarthropathy related gastrointestinal complication has distinctive clinical and pathological characteristics: two cases report and review of the literature. Orphanet J Rare Dis. 2019;14(1):297. doi: https://doi.org/10.1186/s13023-019-1264-5</mixed-citation><mixed-citation xml:lang="en">Wang Q, Li YH, Lin GL, et al. Primary hypertrophic osteoarthropathy related gastrointestinal complication has distinctive clinical and pathological characteristics: two cases report and review of the literature. Orphanet J Rare Dis. 2019;14(1):297. doi: https://doi.org/10.1186/s13023-019-1264-5</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Marques P, Korbonits M. Approach to the patient with pseudoacromegaly. J Clin Endocrinol Metab. 2022;107(6):1767-1788. doi: https://doi.org/10.1210/clinem/dgab789</mixed-citation><mixed-citation xml:lang="en">Marques P, Korbonits M. Approach to the patient with pseudoacromegaly. J Clin Endocrinol Metab. 2022;107(6):1767-1788. doi: https://doi.org/10.1210/clinem/dgab789</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Diggle CP, Carr IM, Zitt E, et al. Common and recurrent HPGD mutations in Caucasian individuals with primary hypertrophic osteoarthropathy. Rheumatology (Oxford). 2010;49(6):1056-1062. doi: https://doi.org/10.1093/rheumatology/keq048</mixed-citation><mixed-citation xml:lang="en">Diggle CP, Carr IM, Zitt E, et al. Common and recurrent HPGD mutations in Caucasian individuals with primary hypertrophic osteoarthropathy. Rheumatology (Oxford). 2010;49(6):1056-1062. doi: https://doi.org/10.1093/rheumatology/keq048</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Chen H, Hu B, Lv X, et al. Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis. Nat Commun. 2019;10(1):181. doi: https://doi.org/10.1038/s41467-018-08097-7</mixed-citation><mixed-citation xml:lang="en">Chen H, Hu B, Lv X, et al. Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis. Nat Commun. 2019;10(1):181. doi: https://doi.org/10.1038/s41467-018-08097-7</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Jagdish RK. Bisphosphonates use in a Case of Pachydermoperiostosis. Austin J Orthop Rheumatol. 2017;4(1):1046. doi: https://doi.org/10.26420/austinjorthopaderheumatol.2017.1046</mixed-citation><mixed-citation xml:lang="en">Jagdish RK. Bisphosphonates use in a Case of Pachydermoperiostosis. Austin J Orthop Rheumatol. 2017;4(1):1046. doi: https://doi.org/10.26420/austinjorthopaderheumatol.2017.1046</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Jagdish RK, Bhatnagar MK, Malhotra A, Aggarwal R, Shailly. Bisphosphonates use in Pachydermoperiostosis. J Assoc Physicians India. 2019;67(9):87-90</mixed-citation><mixed-citation xml:lang="en">Jagdish RK, Bhatnagar MK, Malhotra A, Aggarwal R, Shailly. Bisphosphonates use in Pachydermoperiostosis. J Assoc Physicians India. 2019;67(9):87-90</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Sonthalia N, Mukherjee K, Saha A, Talukdar A. Treatment of hypertrophic osteoarthropathy in the case of pulmonary metastasis secondary-to-nasopharyngeal carcinoma with zoledronic acid: an enlightening experience. Case Reports. 2012;2012(1):bcr2012006759-bcr2012006759. doi: https://doi.org/10.1136/bcr-2012-006759</mixed-citation><mixed-citation xml:lang="en">Sonthalia N, Mukherjee K, Saha A, Talukdar A. Treatment of hypertrophic osteoarthropathy in the case of pulmonary metastasis secondary-to-nasopharyngeal carcinoma with zoledronic acid: an enlightening experience. Case Reports. 2012;2012(1):bcr2012006759-bcr2012006759. doi: https://doi.org/10.1136/bcr-2012-006759</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Голоунина О.О., Белая Ж.Е. Бисфосфонаты: 50 лет в медицинской практике // Consilium Medicum. — 2020. — Т. 22. — №4. — С. 66-73. doi: https://doi.org/10.26442/20751753.2020.4.200102</mixed-citation><mixed-citation xml:lang="en">Golounina OO, Belaya ZE. Bisphosphonates: 50 years in clinical practice. Consilium Medicum. 2020;22(4):66-73. (In Russ.). doi: https://doi.org/10.26442/20751753.2020.4.200102</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Karunasree N, Narasimha R. Management of Pachydermoperiostosis with Bisphosphonates, Isotretinoin and Colchicine-A Case Report. International Journal of Pharmacy and Biological Sciences. 2015;(5):18-23.</mixed-citation><mixed-citation xml:lang="en">Karunasree N, Narasimha R. Management of Pachydermoperiostosis with Bisphosphonates, Isotretinoin and Colchicine-A Case Report. International Journal of Pharmacy and Biological Sciences. 2015;(5):18-23.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Seifert W, Beninde J, Hoffmann K, et al. HPGD mutations cause cranioosteoarthropathy but not autosomal dominant digital clubbing. Eur J Hum Genet. 2009;17(12):1570-1576. doi: https://doi.org/10.1038/ejhg.2009.104</mixed-citation><mixed-citation xml:lang="en">Seifert W, Beninde J, Hoffmann K, et al. HPGD mutations cause cranioosteoarthropathy but not autosomal dominant digital clubbing. Eur J Hum Genet. 2009;17(12):1570-1576. doi: https://doi.org/10.1038/ejhg.2009.104</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Tüysüz, B., Yılmaz, S., Kasapçopur, Ö. et al. Primary hypertrophic osteoarthropathy caused by homozygous deletion in HPGD gene in a family: changing clinical and radiological findings with long-term follow-up. Rheumatol Int. 2014;34(11):1539-1544. doi: https://doi.org/10.1007/s00296-014-3037-8</mixed-citation><mixed-citation xml:lang="en">Tüysüz, B., Yılmaz, S., Kasapçopur, Ö. et al. Primary hypertrophic osteoarthropathy caused by homozygous deletion in HPGD gene in a family: changing clinical and radiological findings with long-term follow-up. Rheumatol Int. 2014;34(11):1539-1544. doi: https://doi.org/10.1007/s00296-014-3037-8</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Yüksel-Konuk B, Sırmacı A, Ayten GE, et al. Homozygous mutations in the 15-hydroxyprostaglandin dehydrogenase gene in patients with primary hypertrophic osteoarthropathy. Rheumatol Int. 2009;30(1):39-43. doi: https://doi.org/10.1007/s00296-009-0895-6</mixed-citation><mixed-citation xml:lang="en">Yüksel-Konuk B, Sırmacı A, Ayten GE, et al. Homozygous mutations in the 15-hydroxyprostaglandin dehydrogenase gene in patients with primary hypertrophic osteoarthropathy. Rheumatol Int. 2009;30(1):39-43. doi: https://doi.org/10.1007/s00296-009-0895-6</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Radhakrishnan P, Jacob P, Nayak SS, et al. Digital clubbing as the predominant manifestation of hypertrophic osteoarthropathy caused by pathogenic variants in HPGD in three Indian families. Clin Dysmorphol. 2020;29(3):123-126. doi: https://doi.org/10.1097/MCD.0000000000000324</mixed-citation><mixed-citation xml:lang="en">Radhakrishnan P, Jacob P, Nayak SS, et al. Digital clubbing as the predominant manifestation of hypertrophic osteoarthropathy caused by pathogenic variants in HPGD in three Indian families. Clin Dysmorphol. 2020;29(3):123-126. doi: https://doi.org/10.1097/MCD.0000000000000324</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
